Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2128924
                    [Title] => FDA warns public against black market tocilizumab
                    [Summary] => Health authorities have said the country's supply of the arthritis drug will remain limited until the end of the year. 
                    [DatePublished] => 2021-09-22 12:36:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806910
                    [AuthorName] => Christian Deiparine
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/22/chapel-22021-08-2215-50-34_2021-09-22_12-25-26595_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2127663
                    [Title] => Philippines can’t secure enough Tocilizumab – Galvez
                    [Summary] => The Philippines is encountering difficulties in securing enough supply of Tocilizumab, a drug administered to COVID-19 patients, a Palace official said yesterday.
                    [DatePublished] => 2021-09-17 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805309
                    [AuthorName] => Alexis Romero
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/16/toc_2021-09-16_21-41-41173_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2124855
                    [Title] => DOH warns of imprisonment, fine for tocilizumab price gougers
                    [Summary] => The Department of Health warned Saturday that sellers of tocilizumab who do not follow its suggested retail price would be jailed and fined, amid a global shortage in the drug used off-label to treat patients hospitalized due to COVID-19
                    [DatePublished] => 2021-09-04 15:19:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/02/chapel-icu-4_2021-09-02_18-16-18_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 937146
                    [Title] => Right medication helps rheumatoid arthritis patient live normally anew
                    [Summary] => 
Jean Vasquez was a hard worker at the University of the East Ramon Magsaysay Medical Center. She was a cashier in the outpatient clinic and was accustomed to meeting different types of patients and seeing many different types of conditions.

                    [DatePublished] => 2013-05-02 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 786113
                    [Title] => Arthritis patients can live healthy, normal lives
                    [Summary] => 
Anna was always very active. When she was younger, she was heavily into kickboxing, scuba diving, and several other high-impact sports and exercises.
                    [DatePublished] => 2012-03-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 784577
                    [Title] => Helping rheumatoid arthritis patients live healthy, normal lives
                    [Summary] => 
Anna was always very active.
                    [DatePublished] => 2012-03-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 691717
                    [Title] => Roche announces new study data  on rheumatoid arthritis treatment
                    [Summary] => 
Roche recently announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress.
                    [DatePublished] => 2011-06-02 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 682217
                    [Title] => Roche drug for treating systemic juvenile  idiopathic arthritis gets US FDA approval
                    [Summary] => 
The United States Food and Drug Administration (FDA) has approved Roche’s drug tocilizumab for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two and older.
                    [DatePublished] => 2011-05-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

TOCILIZUMAB

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2128924
                    [Title] => FDA warns public against black market tocilizumab
                    [Summary] => Health authorities have said the country's supply of the arthritis drug will remain limited until the end of the year. 
                    [DatePublished] => 2021-09-22 12:36:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1806910
                    [AuthorName] => Christian Deiparine
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/22/chapel-22021-08-2215-50-34_2021-09-22_12-25-26595_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2127663
                    [Title] => Philippines can’t secure enough Tocilizumab – Galvez
                    [Summary] => The Philippines is encountering difficulties in securing enough supply of Tocilizumab, a drug administered to COVID-19 patients, a Palace official said yesterday.
                    [DatePublished] => 2021-09-17 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805309
                    [AuthorName] => Alexis Romero
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/16/toc_2021-09-16_21-41-41173_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2124855
                    [Title] => DOH warns of imprisonment, fine for tocilizumab price gougers
                    [Summary] => The Department of Health warned Saturday that sellers of tocilizumab who do not follow its suggested retail price would be jailed and fined, amid a global shortage in the drug used off-label to treat patients hospitalized due to COVID-19
                    [DatePublished] => 2021-09-04 15:19:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/09/02/chapel-icu-4_2021-09-02_18-16-18_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 937146
                    [Title] => Right medication helps rheumatoid arthritis patient live normally anew
                    [Summary] => 
Jean Vasquez was a hard worker at the University of the East Ramon Magsaysay Medical Center. She was a cashier in the outpatient clinic and was accustomed to meeting different types of patients and seeing many different types of conditions.

                    [DatePublished] => 2013-05-02 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 786113
                    [Title] => Arthritis patients can live healthy, normal lives
                    [Summary] => 
Anna was always very active. When she was younger, she was heavily into kickboxing, scuba diving, and several other high-impact sports and exercises.
                    [DatePublished] => 2012-03-13 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 784577
                    [Title] => Helping rheumatoid arthritis patients live healthy, normal lives
                    [Summary] => 
Anna was always very active.
                    [DatePublished] => 2012-03-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 691717
                    [Title] => Roche announces new study data  on rheumatoid arthritis treatment
                    [Summary] => 
Roche recently announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress.
                    [DatePublished] => 2011-06-02 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 682217
                    [Title] => Roche drug for treating systemic juvenile  idiopathic arthritis gets US FDA approval
                    [Summary] => 
The United States Food and Drug Administration (FDA) has approved Roche’s drug tocilizumab for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two and older.
                    [DatePublished] => 2011-05-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

FDA warns public against black market tocilizumab

By Christian Deiparine | September 22, 2021 - 12:36pm

Health authorities have said the country's supply of the arthritis drug will remain limited until the end of the year.&n...

Headlines

Philippines can’t secure enough Tocilizumab – Galvez

By Alexis Romero | September 17, 2021 - 12:00am

The Philippines is encountering difficulties in securing enough supply of Tocilizumab, a drug administered to COVID-19 patients,...

Headlines

DOH warns of imprisonment, fine for tocilizumab price gougers

September 4, 2021 - 3:19pm

The Department of Health warned Saturday that sellers of tocilizumab who do not follow its suggested retail price would be...

Headlines

Right medication helps rheumatoid arthritis patient live normally anew

May 2, 2013 - 12:00am

Jean Vasquez was a hard worker at the University of the East Ramon Magsaysay Medical Center. She was a cashier in the outpatient clinic and was accustomed to meeting different types of patients and seeing many different...

Science and Environment

Arthritis patients can live healthy, normal lives

March 13, 2012 - 12:00am

Anna was always very active. When she was younger, she was heavily into kickboxing, scuba diving, and several other high-impact sports and exercises.

Health And Family

Helping rheumatoid arthritis patients live healthy, normal lives

March 8, 2012 - 12:00am

Anna was always very active.

Science and Environment

Roche announces new study data on rheumatoid arthritis treatment

June 2, 2011 - 12:00am

Roche recently announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress.

Science and Environment

Roche drug for treating systemic juvenile idiopathic arthritis gets US FDA approval

May 5, 2011 - 12:00am

The United States Food and Drug Administration (FDA) has approved Roche’s drug tocilizumab for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two and older.

Science and Environment